About Numoda
New life for life sciences companies
The three companies of Numoda form a leading provider of specialized services to life sciences companies - trial design, oversight, information technologies, business services, and structured finance. Numoda pioneered and patented new technologies to achieve more successful, rapid, efficient and cost effective clinical trials, and helps promising biotech firms manage essential activities from logistics to budgeting.
Numoda’s financing arm – Numoda Capital Innovations – enables life sciences companies to attract and leverage capital – and invests directly in companies with promising new therapies and treatments. NCI also manages a new venture fund of biotech opportunities and helps life sciences companies find marketing partners.
Taken together, Numoda’s activities strengthen life sciences companies and give credibility to their clinical trial results, thereby improving conditions for attracting capital, licensing therapies and securing marketing partners for ultimate success.
Quick Facts
- A unique range of innovative business advisory, technical, and investment capabilities proven, in many case histories, to benefit life science companies
- 12-year-old company headquartered in Philadelphia, with operations in 50 countries
- 95% trial success rate in reaching endpoints due to de-risking capabilities, using integrated systems to allow proactive management of programs and elimination of the leading reasons for trial delay and failure, e.g. slow enrollment, failure to get compliance, inadequate and inaccurate record keeping, data inconsistencies, failure to report properly, safety reporting, and unaccounted for drug disposition and diagnostic assessments.
- Manages clinical programs of companies in which the Numoda Capital Innovations invests, giving investors confidence that trials are being efficiently run and have a high likelihood of success